Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FuelCell Energy Reports Third Fiscal Quarter 2026 Results; Executes First Data Center Power Agreement, Increases Annualized Production Rate & Focuses on Capacity Expansion
-
Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
Palvella Therapeutics to Participate in Upcoming Healthcare Investor Conferences
-
Tema Photonics & Optical ETF (LAZR) Increases Anthropic Position Ahead of Highly Anticipated IPO
-
Algoma Steel Group Inc. Provides Update on Lake Superior Power Plant Outage
-
Cronos’ brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes
-
FuelCell Energy Reports Third Fiscal Quarter 2026 Results; Executes First Data Center Power Agreement, Increases Annualized Production Rate & Focuses on Capacity Expansion
-
Daktronics, Inc. Announces Fiscal 2027 First Quarter Results
-
BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026
-
Farcast completes Telesat Lightspeed antenna technology demonstration milestone
-
Dyne Therapeutics to Participate in Upcoming Investor Conferences
-
New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies
-
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
-
Rezolute to Participate in Upcoming Investor Conferences
-
Zevra Therapeutics to Present at Upcoming Investor Conferences
-
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
-
Quantum Cyber Appoints Tzvi Lev as Head of Sales, Middle East to Lead GCC Commercial Expansion of Its Autonomous Defense Platform
-
Edible Garden Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
A Previously Unattested Egyptian Title and a Face from Roman Egypt: TimeLine’s 8 September Auction
-
The companies of CSG group will showcase their products at MSPO 2026, the largest trade fair of its kind in Central Europe
-
Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company
-
Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.
-
uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease
-
Charles IT Expands AI and Automation Capabilities Through Acquisition of Descent
-
Teva Announces Positive Topline Results from Phase 2a Study in Celiac Disease for Its Anti-IL-15 Antibody, Further Validating Its Pipeline-in-a-Product Potential
-
Taco Cabana Turns 48 With a Monthlong Celebration
-
Cardiff Oncology to Participate in September 2026 Conferences
-
MoneySimpler Unveils AI Automated Stock & Forex Trading to Boost Income for Social Security Benefits
-
G-III Apparel Group, Ltd. Reports Second Quarter Fiscal 2027 Results and Raises Earnings Guidance
-
Wallbridge Reports Results from 2026 Fenelon PFS Metallurgical Drilling Program
-
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting
-
Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
-
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September
-
Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference
-
Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences
-
Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
-
TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors
-
9/11 and Immigration Panel: 25 Years of Lessons and Unfinished Business
-
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
WRAP Moves to Operationalize De-Escalation, Advances New BolaWrap 150 Doctrine Toward California POST Certification
-
By Popular Demand: Tilray Beverages Makes Popsicle Hard Firecracker a Permanent Flavor
-
G-III Apparel Group, Ltd. Reports Second Quarter Fiscal 2027 Results and Raises Earnings Guidance
-
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
-
GoldInxs Announces Completion of Field Program at Millar Property in British Columbia’s Golden Triangle
-
Ollie’s Bargain Outlet Holdings, Inc. Announces Second Quarter Fiscal 2026 Results
-
GXO Announces Participation in Upcoming Investor Conferences
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
Verano Announces Upcoming Conference Participation
-
European Wax Center Releases Limited Edition Golden Orchard Body Butter and Body Polish for Post-Wax Skincare
-
Climb Bio to Present at Upcoming Investor Conferences
